Rodriguez-Otero Paula, Reis Joana, Alfonso-Pierola Ana, Salas-Benito Diego, Giraldez Miriam, Azanza Jose Ramón, Ponz-Sarvise Mariano
Paula Rodriguez-Otero, MD, PhD, Department of Hematology, Clínica Universidad de Navarra, Pamplona, Spain; Joana Reis, Central Unit for Clinical Trials, Clínica Universidad de Navarra, Pamplona, Spain; Ana Alfonso-Pierola, MD, PhD, Department of Hematology, Clínica Universidad de Navarra, Pamplona, Spain; Diego Salas-Benito, MD, Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain; Miriam Giraldez, PharmD, PhD, Department of Pharmacy, Clínica Universidad de Navarra, Pamplona, Spain; Jose Ramón Azanza, MD, PhD, Department of Clinical Pharmacology, Clínica Universidad de Navarra, Pamplona, Spain; and Mariano Ponz-Sarvise, MD, PhD, Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain.
JCO Glob Oncol. 2020 Jun;6:904-905. doi: 10.1200/GO.20.00247.